Ambulatory oxygen in interstitial lung disease

Not Applicable

Completed

• Conditions: Interstitial Lung Disease; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12617000054314
• Lead Sponsor: Dr Yet Hong Khor

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-01-11
• Study Completion: 2018-10-23
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

* Able to give written informed consent
* Chronic interstitial lung disease of any aetiology
* Able to perform a 6-minute walk test
* Desaturates to < 90% on room air during the 6-minute walk test
* Modified Medical Research Council Dyspnoea Scale greater than or equal to 1
* Participated in pulmonary rehabilitation within the 12 months prior to enrolment or has declined the offer of participation in pulmonary rehabilitation.

Exclusion Criteria

* Current domiciliary or ambulatory oxygen use
* Patients meeting criteria for long term oxygen therapy based on measured arterial partial pressure of oxygen (defined as stable daytime PaO2 less than or equal to 55 mmHg, or stable daytime PaO2 56-59 mmHg with evidence of hypoxic organ damage (including right heart failure, pulmonary hypertension or polycythaemia)
* Significant communication or locomotor difficulties
* Current smokers
* Patients with concurrent chronic obstructive pulmonary disease (FEV1/FVC <60% and elevated RV/TLC ratio)
* Unstable disease in the last 4 weeks before screening
* Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified